BioSpace News Archive

Axcella Health (Nasdaq: AXLA), a biotechnology company pioneering the research and development of novel multifactorial interventions to address dysregulated metabolism and support health, today announced that Bill Hinshaw, President and CEO, will present a corporate update at the Wedbush PacGrow Healthcare Conference, which is taking place at the Parker New York in New York City on August 14, 2019 at 1:55pm ET.

California-based StemCyte, Inc., the pioneer in newborn stem cell therapy, is proud to announce the strategic partnership renewal with Sharp HealthCare, which includes Sharp Mary Birch Hospital for Women & Newborns. It is the largest and most extensive freestanding center for women’s health in Southern California with over 8,000 babies delivered annually.

111, Inc., a leading integrated online and offline healthcare platform, announced its winning of the 2019 China Healthcare Industry Best Company Award at the 4th China Healthcare Industry Summit held in Beijing.

InMode Ltd., announced the pricing of its initial public offering of 5,000,000 ordinary shares at an initial public offering price of $14.00 per ordinary share.

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye, today reported financial results for the second quarter ended June 30, 2019,

Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with chronic skin conditions, today reported financial results for the quarter ended June 30, 2019 and provided a corporate update.